Selective PPARalpha agonist (EC50=0.63, 32 and >100 µM for PPARalpha,gamma and delta, respectively).1 Displays anti-inflammatory activity2 and reduces LPS-induced inflammation in alveolar epithelial cells3. Induces ''browning of white adipocytes in combined treatment wi
* VAT and and shipping costs not included. Errors and price changes excepted